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Background: A Nox2 containing NADPH oxidase (Nox2) is involved in the global oxidative stress found in 
dietary obesity and metabolic disorders. However, the effects of high fat diet (HFD) on cardiac Nox2 activation 
and signaling in left ventricular hypertrophy (LVH) remain unknown. 
Methods: Left ventricular (LV) tissues isolated from C57BL/6J wild‐type (WT) and Nox2 knockout (Nox2KO) 
mice (11 months old, n = 6 per group) after 4 months of HFD treatment were used. Cardiomyocyte sizes were 
measured digitally on LV cross-sections. The levels of cardiac reactive oxygen species (ROS) production was 
determined using lucigenin‐chemiluminescence and in situ dihydroethidium (DHE) fluorescence. The levels of 
Nox subunit expression and redox signaling were examined by immunoblotting and immunofluorescence.  
Results: In comparison to WT normal chow diet control hearts, WT HFD hearts had 1.8-fold increases in 
cardiomyocyte size, a sign of cardiac hypertrophy, and this was accompanied with ≥2-fold increase in the levels 
of ROS production, Nox2 expression and the phosphorylation of Akt and ERK1/2. Increased ROS production 
measured in HFD heart homogenates was inhibited to control levels by Tiron (a cell membrane permeable O2• − 
scavenger), diphenyleneiodonium (DPI, a flavohaemoprotein inhibitor) and Nox2 ds-tat (a Nox2 assembly 
inhibitor). However, all of these abnormalities were significantly reduced or absent in Nox2KO hearts under the 
same HFD. 
Conclusions: Nox2 activation in response to dietary obesity and metabolic disorders plays a key role in cardiac 
oxidative stress, aberrant redox signaling and cardiomyocyte hypertrophy. Knockout of Nox2 protects hearts 
from oxidative damage associated with obesity and metabolic disorders.  
 




Obesity and diets high in fat are frequently associated with left ventricular hypertrophy (LVH) which is 
a principal cardiovascular complication that increases the risk of mortality [1]. As obesity is a chronic condition, 
the majority of cases had emerged in the middle-aged population. However, recently the rate of childhood and 
adolescent obesity soars [2], rendering investigation of the pathophysiology of obesity of even greater 
importance. Regular high dietary fat intake encourages health complications including hypertension, insulin 
resistance and dyslipidaemia which largely influence the structure and mechanics of the energy-demanding 
myocardium, instigating pathological adaptations comprising myocardial hypertrophy, remodelling and fibrosis 
[3].  
Increasing attention is directed toward NADPH Oxidase 2 (Nox2), a principle generator of bioactive 
superoxide (O2•−), due to its influence in diet-induced oxidative damage in cardiovascular cell types [4]. 
Although crucial at low levels, excess Nox2-mediated O2•− burden causes damage to macromolecules and 
organelles whilst impairing intracellular signaling events involving metabolic sensitivity [4]. Among the seven 
multisubunit Nox homologs of 65kDa, Nox2 is largely expressed in vascular cell types including endothelial 
cells, vascular smooth muscle cells and, principally, in cardiomyocytes mediating important roles in myocardial 
growth, remodelling and injury [5,6]. The heterodimeric flavohaemoprotein assembles at the plasma membrane 
after recruiting its subunits: Rac, p40phox, p47phox and p67phox to generate the functional complex.  
Multiple pro-hypertrophic stimuli are capable of activating Nox2 such as angiotensin II, mechanical 
stretch and tumour necrosis factor-α [5]. Accumulating evidence indicate that in obesogenic environments of 
chronic HFD intervention Nox2 expression is augmented in skeletal muscle [6] and aorta [7]. In the latter study 
Nox2-derived oxidative stress is reported to be essential for insulin response impairments, and often involves 
the redox-sensitive signaling intermediates Akt, ERK1/2 and p38MAPK [6-8]. However, this has not been 
investigated in myocardium. HFD feeding reduces insulin sensitivity as early as five days of intervention [9], 
associates with oxidative stress and promotes vascular damage involving cardiac remodelling, hypertrophy and 
apoptosis [10]. Aortic Nox2 overexpression occurs in HFD-fed ApoE knockout mice in unison with increased 
activation of both Akt and ERK1/2 and is associated with endothelial dysfunction [11]. Moreover, it has been 
reported that caloric restriction reverses endothelial oxidative damage in these conditions [12]. As obesity is an 
independent predictor of LVH, understanding the contribution of lipid-induced oxidative stress caused by Nox2 
in the manifestation of LVH is valuable.  
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Recent promising evidence reveal the divergent roles of the pleiotropic Nox2 enzyme in endothelial 
cells compared with cardiomyocytes that, in pathological conditions, cause cell-type specific metabolic 
decline [13]. The importance of Nox signaling was reported in an experimental animal model of LVH, wherein 
ERK1/2 and p38MAPK activation mirrored Nox activity and were activated in response to pressure-overload 
[14]. Despite these new insights, there is insufficient evidence describing redox signaling activation and 
mechanism/s of HFD-induced Nox2 activation in the heart. Herein, utilising a mouse model of middle-age (11 
months) HFD-induced metabolic syndrome, we demonstrate a pivotal role of myocardial HFD-induced Nox2 
redox signaling in promoting LVH. 
   
5 
 
Materials and Methods  
Reagents 
The chemiluminescent probe, Bis-N-methylacridinium nitrate (lucigenin, catalogue no. 2315-97-1); the reagents 
L-NAME (N5751), Rotenone (R8875), Oxypurinol (O6881), Diphenyleneiodonium chloride (DPI, D2926), 
Triton X-100 (T8787) and Tiron (D7389); fluorescein isothiocyanate (FITC)-conjugated wheat germ agglutinin 
(Lectin, L4895) and; fluorochrome-conjugated anti-goat (C2821) or anti-rabbit (C2306) secondary antibodies 
were purchased from Sigma-Aldrich, Dorset, UK and gp91 ds-tat (DS-TAT, AS-63818) was bought from 
AnaSpec, Fremont, USA. NADPH (AC328742500) was purchased from Thermo Fisher Scientific, Waltham, 
MA, USA. Dihydroethidium (DHE, D11347) was from Invitrogen, Paisley, UK. Polyclonal antibodies targeting 
Nox2 (sc-20782), Nox4 (sc-30141), phospho-Akt1/2/3 (sc-16646-R), total Akt1/2/3 (sc-8312), total ERK1/2 
(sc-292838), total-p38MAPK (sc-535), α-tubulin (sc-5546) and the monoclonal antibody targeting phospho-
p38MAPK (sc-166182) were from Santa Cruz Biotechnology, Dallas, TX, USA. Phospho-ERK1/2 (#9101) was 
purchased from Cell Signaling Technology, Danvers, MA, USA. 
  
Animal samples and information 
 The cardiac tissue samples used for this study were shared from the animal models [male littermates of 
C57BL/6J WT and Nox2 knockout (Nox2KO) mice, n = 6 per group] generated at the University of Surrey and 
published previously [7]. Animal care and experimentation procedures complied fully with approved standards 
endorsed in the Guidance on the Operation of the Animals (Scientific Procedures) Act 1986, UK set by the 
Home Office and the local Animals Ethics Committee of the University of Surrey. At 7 months of age, mice 
were randomly grouped to be fed either a HFD: 45% kcal fat, 20% kcal protein and 35% kcal carbohydrate 
(Special Diets Services, Essex, UK), or a normal chow diet (NCD): 13% kcal fat, 29% kcal protein and 58% 
kcal carbohydrate (LabDiet Ltd, London, UK) for a period of 16 weeks. The following metabolic changes 
occurred in HFD WT mice after dietary intervention: on average the body weights were increased by 23.4% in 
NCD WT mice, 66.9% in HFD WT mice, 11.6% in NCD Nox2KO mice and, 41.1% in HFD Nox2KO mice; 
blood pressure was increased by 4.8% in NCD WT mice, 18.7% in HFD WT mice, decreased by 1.2% in NCD 
Nox2KO mice and, increased by 5.7% in HFD Nox2KO mice. In comparison to NCD controls, heart weights 
were increased by 14.9% in HFD WT mice and by 3.5% in HFD Nox2KO mice and low density lipoprotein 




Superoxide (O2•−) measurement 
Cardiac LV tissues of C57BL/6J mice in each group (NCD WT, NCD Nox2KO, HFD WT and HFD 
Nox2KO; n = 6 per group) were isolated. Disintegrated and homogenised LV tissue was analysed for O2•− 
generation by means of lucigenin-chemiluminescence (Lumistar, BMG Labtech GmbH, Ortenberg, Germany) 
using 5 μM of lucigenin as previously described [15]. A O2•− scavenger, Tiron (1 M), confirmed O2•− generation. 
Prior to measurement of O2•−, the inhibitors targeting nitric oxide synthases (L-NAME, 100 μM), the 
mitochondrial complex-1 enzymes (Rotenone, 50 μM), xanthine oxidases (Oxypurinol, 250 μM) and flavo-
proteins (DPI, 20 μM or ds-tat, 10 μM) were administered. In situ production of O2•− in intact LV cardiac cells 
was measured using the redox indicator DHE. Intact LV sections (6 µm) were produced using a cryostat (Bright 
Instruments, Bedfordshire, UK) from tissue (3 x 3 mm) obtained from a lower LV region of the harvested 
mouse hearts. DHE fluorescence was performed as previously described [16]. Within 7 min of staining, images 
were captured using the Oxion inverted fluorescent microscope (Euromex, Arnhem, Netherlands) at excitation 
518 nm, emission 605 nm. Using HCImageLive (x64) software, fluorescence intensity was quantified, 
calculated from at least 10 random fields (254.3 × 254.3 μm) for each section, 3 sections per sample and 6 
animals per group. 
 
Immunofluorescence staining 
Frozen LV cryosections (6 μm) were fixed in a 1:1 methanol:acetone solution and blocked using 2% 
BSA with Triton in PBS 1 h at room temperature inside a dark humidity chamber. Primary antibodies (1:100 
dilution) were applied to sections and incubated as mentioned. Polyclonal antibodies targeting: the isoforms 
Nox1, Nox2 and Nox4; the kinases phospho-Akt1/2/3, total Akt1/2/3, phospho-ERK1/2, total ERK1/2, 
phospho-p38MAPK, total-p38MAPK and; the loading control α-tubulin were used to perform the 
immunostaining. For the analysis of cardiomyocyte morphology, FITC-conjugated lectin was used. Lectin 
labeling has been reported to specifically and visibly define single cardiomyocytes for morphological analysis 
and calculation of myocyte size [17]. Fluorochrome-conjugated anti-goat or anti-rabbit (1:1000 dilution) 
secondary antibodies were added to the primary antibody-probed sections and incubated as described. Normal 
rabbit/goat antibody (5 μg/ml) was used as a negative control. Within 12 h of slide preparation, observation 
under the Oxion inverted fluorescent microscope was performed (Euromex, Arnhem, Netherlands). The 





  Immunoblotting was performed as previously described [18], where protein samples were loaded at a 
concentration of 40 μg per lane. The Biospectrum AC Imaging System (UVP, Cambridge, UK) was used to 
digitally capture images and to quantify the optical densities of protein bands normalized to loading control 
bands.  
 
Data and statistical analysis 
 All data are presented as mean (SEM). There were 6 mice per group used for the study and experiments 
were repeated 3 times with a duplicate of each sample per experiment. GraphPad Prism 5 software was used to 
perform one-way or two-way analysis of variance (ANOVA). Bonferroni post-tests were then performed and 




Nox2KO improves excessive cardiac O2•- generation from chronic HFD feeding 
 NADPH-dependent O2•− production was significantly higher for HFD WT hearts than corresponding 
WT controls (Figure 1a and b). Tiron addition, a cell membrane permeable O2•− scavenger, significantly reduced 
the signal, verifying O2•− measurement. Contrastingly, there were significantly lower levels of NADPH-
dependent O2•− production in Nox2KO hearts compared to HFD WT values (Figure 1b). Inhibition significantly 
reduced O2•− levels by Tiron, DPI (an inhibitor of flavoproteins) and DS-TAT (an inhibitor of Nox assembly) 
with no significant difference observed under the influence of L-NAME (an inhibitor of nitric oxide synthases), 
Rotenone (an inhibitor of mitochondrial complex 1 enzymes) nor Oxypurinol (an inhibitor of xanthine oxide 
synthases) (Figure 1c). In situ intensities of tiron-inhibitable O2•− generation was significantly greater in HFD 
WT LV sections, as opposed to their NCD WT controls, and was significantly dampened in HFD Nox2KO LV 




Figure 1. Superoxide (O
2
•-
) generation detected by dual methodology in wild-type (WT) and Nox2 knockout 
(Nox2KO) hearts after high fat diet (HFD) intervention. Lucigenin-chemiluminescence was used to acquire: 
(a) representative kinetic measurements of O
2
•-
 production in relative light units (RLU) where NADPH substrate 
was added at 4 min and Tiron at 17 min (dashed lines) and; (b) bar figure representing O
2
•-
 production. (c) 
Lucigenin-chemiluminescence detection of enzyme inhibition of O
2
•-
 in HFD WT hearts. DPI, diphenylene 




























































































































































of representative in situ O
2
•-
 generation (left panel). Scale bar = 50 μm. Fluorescence intensity was quantified for 
tiron-inhibitable production (right panel). Fluorescence intensity was calculated from a minimum of 10 random 
fields (254.3 × 254.3 μm) per 3 sections in each group. *p < 0.05, significantly different from normal chow diet 
(NCD) WT values; †p < 0.05, significantly different from HFD WT values. n = 6 mice per group. 
 
 
HFD-induced expression of NADPH Oxidases  
HFD WT hearts had significantly higher levels of Nox2 immunoblot protein expression, but not Nox1 
or Nox4 compared to NCD WT controls (Figure 2a). Confirming the Nox2KO, NCD and HFD Nox2KO hearts 
had significantly reduced Nox2 expression levels compared to HFD WT hearts. Nox4 was significantly 
increased in both NCD and HFD Nox2KO hearts (Figure 2a, right lower panel) which was not observed for 
Nox1, suggesting a compensatory upregulation of Nox4 in the absence of Nox2 regardless of HFD-intervention. 
Nox2 immunofluorescence staining levels were significantly higher in HFD WT hearts than NCD WT controls 





Figure 2. Left ventricular Nox protein expression subject to normal chow diet (NCD) and high-fat diet 
(HFD). (a) Western blot analysis confirming expression levels in wild-type (WT) and Nox2 knockout (Nox2KO) 
hearts in NCD (left panel) and HFD (right panel) conditions. The loading control used was α-tubulin. Bar 
represents the mean (SEM) of digitally quantified optical densities (OD) of gel bands normalized to α-tubulin 
levels. Representative gel bands are shown (upper left panel). (b) Representative immunofluorescence staining 
using gp91phox antibody targeting Nox2 (red) and DAPI for nuclear staining (blue). Rightmost panel represents 
merged composites. The fluorescence intensity of individual molecule was quantified to generate the 
quantification bar figure from 10 images at X40 magnification captured from 3 sections of 6 μm thickness per 
group (right panel). Scale bar = 50μm. Data are presented as mean (SEM). *p < 0.05, significantly different from 
corresponding NCD values, 
†
p < 0.05, significantly different from WT HFD values. n = 6 mice per group. 
 


















































































Nox2-mediated altered redox signaling in the establishment of left ventricular hypertrophy 
 The cross-sectional area (CSA) of lectin-stained left ventricular (LV) morphology was significantly 
greater in HFD WT hearts as compared to NCD controls, which was reduced significantly in Nox2KO hearts 
(Figure 3a), suggesting a role of Nox2 in the hypertrophic response. Pro-hypertrophic kinase expression levels 
of p-Akt and p-ERK1/2 were significantly increased in the immunostaining of HFD WT sections compared to 
NCD controls whereas this activation of Akt and ERK1/2 was significantly rescued to NCD levels in Nox2KO 
sections, indicating a role of Nox2 in the stimulation of Akt and ERK1/2 under dietary induced conditions 
(Figure 3b and c). Strengthening these findings, p-Akt and p-ERK1/2 expression by Western blot analysis were 
significantly increased in HFD WT hearts compared with NCD WT values, p < 0.05 (Figure 4a, b and c). In 
HFD-fed Nox2KO hearts however, this expression was significantly reduced for both p-Akt and p-ERK1/2 
(Figure 4b and c). P-p38MAPK levels rose significantly in HFD Nox2KO hearts in comparison to NCD 
Nox2KO controls, p < 0.05 (Figure 4d). However, the increase in the levels of p-p38MAPK in HFD WT hearts 
was not found to be significant. 
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Figure 3. Cardiomyocyte size and immunofluorescence staining of phosphorylated Akt 1/2/3 (P-Akt 1/2/3) 
and ERK1/2 (P-ERK1/2) on left ventricular (LV) cryosections. (a) Cardiomyocyte membrane visualization by 
immunofluorescence staining using FITC-conjugated wheat germ agglutinin on LV sections (left panel). The 
cross-sectional area (μm2) was quantified and calculated using 10 random fields taken from 3 sections per sample 
(right panel). Representative visualization of sections using: (b) P-Akt1/2/3 antibody (red) and; (c) P-ERK1/2 



















































































































antibody (red) with DAPI for nuclear staining (blue). Rightmost lane represents merged composites. The 
fluorescence intensity of individual molecules was quantified to generate the quantification bar figure from 10 
images at X40 magnification captured from 3 sections of 6 μm thickness per group (right panel). Scale bar = 50 
μm. *p < 0.05, significantly different from corresponding normal chow diet (NCD) values. †p < 0.05, significantly 
different from corresponding wild-type (WT) values. One-way ANOVA. n = 6 mice per group. 
 
 
Figure 4. Western blot detection of Akt, ERK1/2 and p38MAPK phosphorylation in cardiac homogenates 
administered different diets. (a) Representative kinase expression levels in WT (left panel) and Nox2KO (right 
panel) hearts under non-chow diet (NCD) or high-fat diet (HFD) conditions. The loading control used was α-
tubulin. Bar represent the mean (SEM) of digitally quantified optical densities (OD) of gel bands normalized to α-
tubulin levels of the kinases: (b) Akt1/2/3; (c) ERK1/2 and; (d) p38MAPK. Activated forms of the protein 
phospho-Akt (P-Akt), phospho-ERK1/2 (P-ERK1/2) and phospho-p38MAPK (P-p38MAPK) were quantified 
relative to total protein (T-Akt, T-ERK1/2 and T-p38MAPK, respectively). *p < 0.05, significantly different from 
NCD values, †p < 0.05, significantly different from corresponding HFD values. One-way ANOVA. n = 6 mice 
per group. 
  
a.  Representative examples of Western blots
WT Nox2KO
c. Quantification of P-ERK1/2
b. Quantification of P-Akt1/2/3




























































Presently, Nox2 is acknowledged as a key influence in global metabolic oxidative disorder and 
cardiovascular dysfunction [4]. Herein, the novel findings are that a HFD evokes: (1) excessive Nox2-mediated 
cardiac oxidative stress to endorse LVH; (2) increased Nox2-dependent activation of Akt, ERK1/2, but not 
p38MAPK in myocardium. For the first time it is reported that the growth regulating kinases Akt and ERK1/2 
are found to be partly Nox2-driven upon lipid stimulation to promote cardiac hypertrophy in middle-aged mice. 
However, despite evidence of pro-hypertrophic roles of the kinase p38MAPK [19], under HFD this study failed 
to observe its activation.  
Individuals consuming westernised diets have greater prevalence of concentric LVH [20]. At the stages 
of obesity, pressure-overload establishes cardiomyocyte enlargement, increases in ventricular dimensions, 
fibrosis and dysfunction [21]. It is acknowledged that the intracellular mechanisms by which lipid-stimulated 
cardiac hypertrophy occurs remains incompletely understood [22]. This study has provided insight of the pro-
hypertrophic influence of cardiac Nox2 in the alteration of cardiomyocyte morphology in the mouse model of 
HFD-induced obesity. It is known that Nox2-derived ROS induces phenotypic changes such as endothelial 
dysfunction, interstitial fibrosis, myocardial contractility and myocyte hypertrophy [7]. However, others report 
LVH in response to pressure-overload did not require the action of Nox2 though other cardiac abnormal events 
such as fibrosis appeared to be Nox2-dependent [23]. Nox2-derived ROS is shown to be important for cardiac 
hypertrophy in response to angiotensin II [24], after myocardial infarction [23] and upon doxorubicin treatment 
[25]. It has been postulated that Nox2 mediates stimuli-specific roles in the promotion of hypertrophy and the 
investigated pathway in the HFD-fed heart appears to be limited and controversial [23]. We introduce fresh 
insight that Nox2 may be stimulated by lipid induction in the establishment of cardiomyocyte hypertrophy. 
It has been proposed that lipid activation of protein synthesis and growth-stimulating genes have 
significant influence in the establishment of LVH [26]. A novel indication revealed herein is that HFD promotes 
Nox2-mediated activation of pro-hypertrophic kinases Akt and ERK1/2 in myocardium. We find that the results 
of increased HFD-induced p-Akt expression in the heart falls in line with a report in myocardium [27], though 
this study did not investigate the contribution of Nox2. Interestingly, diminished levels of HFD-induced 
activated Akt are reported in skeletal muscle and aorta resulting in the impairment of insulin sensitivity after 
HFD feeding [6,7], suggestive of tissue-type specific signaling mediated by HFD-induced Nox2 activation. The 
observation of increased cardiomyocyte p-Akt promoting impaired insulin signaling is suggested to induce 
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insulin resistance via mechanisms relating to the dysregulated activation of GLUT4 transporters despite GLUT4 
translocation remaining intact [22]. Moreover, it has long been suggested that there is an association between 
insulin sensitivity and LV enlargement [28]. P-Akt-mediated development of cardiac hypertrophy in obesogenic 
environments is thought to be mediated via the inhibition of the transcription factor Foxo3a [29]. Therefore, 
increased Akt activation by Nox2 may augment its established dual roles in the activation of programs involved 
in both insulin signaling and cardiomyocyte hypertrophy. Further investigation, beyond that of excessive HFD-
induced Akt activation observed herein, is required to understand the HFD-induced insulin response in the heart 
[22].  
Nox2-derived ROS production caused by excessive glucose and insulin challenge also elicits ERK1/2 
activation, resulting in endothelial cell injury, dysfunction and death [30]. Studies report that Nox2 augments 
endothelial p-ERK1/2 expression after chronic HFD feeding [7,11]. Our findings strongly suggest a contribution 
of myocardial Nox2 in HFD-induced ERK1/2 activation. The results also suggest that Nox2 may not have a role 
in myocardial activation of p38MAPK. The role of the Nox2 isoform in stimulating p38MAPK activation is not 
broadly researched however as fibrotic events causing cardiac remodelling are induced by HFD in vivo [31], the 
role of Nox2-derived O2•− on the activation of the pro-fibrotic p38MAPK in the heart may therefore be 
beneficial to better understand the causes of cardiac remodelling in HFD conditions.  
Reports had implicated Nox2 as an instrumental driver of CVD pathogenesis and topical interest of 
selectively targeting Nox2 as therapeutic strategy has broadened [32]. Global targeting of Nox2 however may be 
unsuitable as evidence indicates this could evoke enhanced susceptibility to infection [33]. Therefore, we 
suggest cardiac-specific targeting of Nox2 activation may be a viable approach to preserving myocardial 
function in metabolic conditions.  
 
Conclusions 
In summary, the current study has provided the novel insight that HFD-induced obesity in middle-aged 
mice is associated with Nox2-mediated cardiac oxidative stress, altered redox signaling events and 
cardiomyocyte expansion. Cardiac-specific targeting of Nox2 may promote a viable therapy to reduce 
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